GEN Exclusives

More »

GEN News Highlights

More »
Sep 28, 2010

Eurofins to Provide Roche GS Junior for Smaller-Scale Projects

  • Eurofins MWG Operon expanded its sequencing capacity with a Roche GS Junior. The GS Junior is the optimum system for sequencing smaller-scale projects that require only one-eighth of the capacity of a GS FLX Titanium run or that would not be suitable for an Illumina run, according to Roche and Eurofins.

    As a consequence, the GS Junior adds a higher degree of flexibility in project planning and will have a positive impact on the turnaround time for small-sized initiatives, Eurofins states. In addition, it allows new possibilities in quality control, e.g., library checking in advance of starting high-throughput sequencing or the validation of next-generation sequencing (NGS) data for molecular diagnostics.

    “We are pleased to integrate this new system in our NGS service pipeline,” says Bruno Poddevin, Eurofins svp, Genomic Services. “It allows our customers to plan experiments that have not been possible in this short timeframe before. In addition, it will secure the high quality of our high-throughput sequencing projects and allow us to develop new applications in a reasonable time and at reasonable cost.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Patients Access to Experimental Medicines?

More »